O “Programa de Generalização das Actividades de Enriquecimento Curricular” como instrumento de regulação da política educativa

A partir de uma abordagem pela “análise das políticas públicas”problema público, tendo como fonte os textos e os discursos oficiais do Governo e de outros actores, pretende-se ensaiar um quadro explicativo para a génese das medidas de generalização do alargamento do horário das escolas do 1.º ciclo e das actividades de enriquecimento curricular (AEC), procurando desocultar as situações problemáticas que lhes estão subjacentes e justificar a sua “entrada” na “agenda política”. Neste processo releva-se o papel dos actores enquanto “empreendedores”, na definição das políticas públicas de educação. Focusing on the public policy analysis, a framework to explain the genesis of the generalization of the extension of school day and curriculum enrichment activities (CEA) in primary schools (1st Cycle) is provided, trying to make clear the problems underneath, as well as to justify their ‘entry’ in the ‘policy agenda’. The inquiry is based on the texts and discourse of government and other stakeholders. In this process the actors’ role is emphasized as "entrepreneurs" in the definition of the public policies for education

Differential expression of CDC25 phosphatases splice variants in human breast cancer cells

Background: CDC25 phosphatases control cell cycle progression by activating cyclin dependent kinases. The three CDC25 isoforms encoding genes are submitted to alternative splicing events which generate at least two variants for CDC25A and five for both CDC25B and CDC25C. An over-expression of CDC25 was reported in several types of cancer, including breast cancer, and is often associated with a poor prognosis. Nevertheless, most of the previous studies did not address the expression of CDC25 splice variants. Here, we evaluated CDC25 spliced transcripts expression in anti-cancerous drug-sensitive and resistant breast cancer cell lines in order to identify potential breast cancer biomarkers. Methods: CDC25 splice variants mRNA levels were evaluated by semi-quantitative RT-PCR and by an original real-time RT-PCR assay. Results: CDC25 spliced transcripts are differentially expres-sed in the breast cancer cell lines studied. An up-regulation of CDC25A2 variant and an increase of the CDC25C5/C1 ratio are associated to the multidrug-resistance in VCREMS and DOXOR breast cancer cells, compared to their sensitive counterpart cell line MCF-7. Additionally, CDC25B2 tran-script is exclusively over-expressed in VCREMS resistant cells and could therefore be involved in the development of certain type of drug resistance. Conclusions: CDC25 splice variants could represent interesting potential breast cancer prognostic biomarkers.